Clinical Trial: Eplerenone for the Treatment of Central Serous Chorioretinopathy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Eplerenone for the Treatment of Central Serous Chorioretinopathy

Brief Summary: To test the effect oral eplerenone versus placebo in patients with central serious chorioretinopathy .